Novartis (Austria)

464 papers and 27.8k indexed citations i.

About

In recent decades, authors affiliated with Novartis (Austria) have published 464 papers, which have received a total of 27.8k indexed citations. Scholars at this organization have produced 209 papers in Molecular Biology, 168 papers in Immunology and 60 papers in Oncology on the topics of T-cell and B-cell Immunology (73 papers), Immune Cell Function and Interaction (54 papers) and Sphingolipid Metabolism and Signaling (52 papers). Their work is cited by papers focused on Immunology (12.6k citations), Molecular Biology (10.0k citations) and Oncology (4.9k citations). Authors at Novartis (Austria) collaborate with scholars in Austria, Switzerland and United States and have published in prestigious journals including Nature, Cell and New England Journal of Medicine. Some of Novartis (Austria)'s most productive authors include Thomas Baumruker, Antal Rot, Andreas Billich, Manfred Auer and Josef G. Meingassner.

In The Last Decade

Fields of papers published by authors at Novartis (Austria)

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers affiliated with Novartis (Austria) at the time of their publication. Nodes represent fields, and links connect fields that are likely to share authors.

Countries citing scholars working at Novartis (Austria)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Novartis (Austria). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Novartis (Austria) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Novartis (Austria) more than expected).

Rankless by CCL
2025